← Open Payments lookup

SHIRLEY KOSS: Open Payments

NPI 1902468457 · FRAMINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$486 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $486

Food & beverage: $486
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.2$138
Novartis Pharmaceuticals Corporation4$82
E.R. Squibb & Sons, L.L.C.3$76
Amgen Inc.3$74
Boston Scientific Corporation1$52
Boehringer Ingelheim Pharmaceuticals, Inc.2$43
Alnylam Pharmaceuticals Inc.1$21

Products named: Kerendia, LEQVIO, CAMZYOS, REPATHA, WATCHMAN FLX, JARDIANCE, AMVUTTRA.

Industry payments across MA — which companies pay providers there.